Text and Data Mining valid from 2019-02-11
Received: 8 September 2017
Accepted: 18 December 2018
First Online: 11 February 2019
Change Date: 17 May 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
: X.S.L. is a cofounder and board member of GV20 Oncotherapy, SAB of 3DMed Care, consultant for Genentech, and stock holder of BMY, TMO, WBA, ABT, ABBV, and JNJ. J.S.L. is a cofounder and board member of Beijing Neoantigen Biotechnology Co. Ltd, and shareholder of BGNE, DVAX, CELG, NKTR, CRSP, and EDIT. K.W.W. serves on the SAB of Nextech, TCR2, and T-scan. He is also a consultant for Novartis. His laboratory has sponsored research agreements with Novartis, BMS, and Astellas. N.H. is a founder and SAB member of Neon Therapeutics and SAB member of IFM Therapeutics.